Search
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
April 30, 2026 - … prices, including previously announced reductions in cash pay prices. Lower realized prices were partially offset by a … prices, including previously announced reductions in cash pay prices. Lower realized prices were partially offset by a … prices, including previously announced reductions in cash pay prices. Lower realized prices were partially offset by a …
Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
April 9, 2026 - … with commercial coverage and $149 per month with self-pay INDIANAPOLIS , April 9, 2026 /PRNewswire/ -- Eli Lilly … starting at $149 per month at the lowest dose for self-pay patients. 1 Eligible and commercially insured people with coverage for Foundayo may pay as little as $25 per month with the Foundayo savings …
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
April 1, 2026 - … $25 per month with commercial coverage and $149 for self-pay INDIANAPOLIS , April 1, 2026 /PRNewswire/ -- Eli Lilly … affordable. Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card. 3 Individuals opting for self-pay can access Foundayo starting at $149 per month for the …
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
March 27, 2026 - … Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients. … Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients. … Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients. …
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12
March 12, 2026 - … Zepbound. Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or … Zepbound. Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or … Zepbound. Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or …
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect
March 16, 2026 - … Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to … Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to … Today, Eli Lilly and Company announced that access to self-pay pricing on the new Zepbound ® (tirzepatide) KwikPen ® for …
Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis
March 16, 2026 - … Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients. … Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients. … Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients. …
Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients
March 5, 2026 - … Zepbound. Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or … Zepbound. Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or … Zepbound. Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or …
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
February 23, 2026 - … multi-dose KwikPen or single-dose vial at the same self-pay price, starting at $299 , available by prescription now … Patients, with a valid prescription, opting for self-pay through LillyDirect ® , can receive all doses of Zepbound … Lilly treatments through LillyDirect, 4 which offers self-pay pricing at a 50% or greater discount compared to the list …
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
February 18, 2026 - … Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or … Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or … Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or …